News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
About the Author - Alex Keown

BioSpace News - By Alex Keown
Earnings Preview: Here's a Look at What to Expect From 7 Biopharmas 1/23/2017
Two Former AllCells Employees Allegedly Took Confidential Info to Launch Cepheus Biosciences 1/23/2017
Trump's Controversial Education Nominee Betsy DeVos Also Linked to Theranos 1/23/2017
485 Eli Lilly (LLY) Employees Will be Out of Work Beginning March 31 1/20/2017
Martin Shkreli's Complaint Leads to a $100 Million FTC Settlement for This Biotech 1/20/2017
Merck & Co. (MRK) Expands Discovery to New South San Francisco Facility in Heart of Bay Area and Looks to Hire 100 Employees 1/20/2017
Theranos Shuts Down Last Remaining Blood-Testing Lab After Another Failed Inspection 1/19/2017
Struggling MannKind (MNKD)'s New Strategy Includes Doubling Its Sales Force 1/19/2017
Sanofi (SNY) Exec Jumps Ship to Helm Merrimack (MACK) 1/19/2017
Embattled Theranos Forms New Advisory Board of Biotech Experts 1/18/2017
ImmunoGen (IMGN) CEO Sees Potential in Company’s Lead ADC Product 1/18/2017
Tiny Ovid Inks a Unique Rare Disease Deal With Drug Giant Takeda (TKPYY) 1/18/2017
Why Bristol-Myers Squibb (BMY) Could be a Takeover Target Soon 1/18/2017
Why the Government Should Pay $156 Billion to Own Gilead (GILD) 1/18/2017
New Grunenthal CEO Forges Ahead with Treatment for Complex Regional Pain Syndrome 1/18/2017
Silicon Valley Exec Meets Trump for FDA Job 1/17/2017
NantKwest CEO (AKA World's Richest Doctor) Rumored to Have Met Trump for Top NIH Job 1/17/2017
Struggling OvaScience (OVAS) Offers CFO Cash to Stay on Board 1/17/2017
MiMedx CEO Allegedly Demanded Employees Donate Cash to Support GOP Candidates Like Tom Price 1/17/2017
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse 1/16/2017
Trump's HHS Nominee and His Ties With Two Massachusetts Biotech Firms 1/16/2017
Trump Says Pharma Getting Away With Murder, Vows to Lower Drug Prices 1/13/2017
Tesaro (TSRO) Craters as the FDA Denies Approval of Rolapitant IV 1/13/2017
And It Gets Worse...Arizona Planning to Sue Theranos Over Faulty Blood Tests 1/13/2017
Gilead (GILD): To Split or Not to Split... 1/13/2017
JPM17: Opko Health (OPK) CEO's Gameplan After Its Recent Growth Hormone Failure 1/13/2017
Merck KGaA (MKGAF.PK) Lays Off Some Employees in Shutdown of Its Massachusetts Accounting Office 1/12/2017
Trump Has Another Top FDA Post to Fill 1/12/2017
JPM17: New Biogen (BIIB) CEO on Groundbreaking Alzheimer's Trial and the Company's Future 1/12/2017
Florida-Based Wearable Device Maker ActiGraph Surges Into 2017 With Big Data Sleep Tech 1/12/2017
Cosmetic Giant L'Oreal Pays $1.3 Billion for Three Skincare Brands From Valeant (VRX) 1/11/2017
JPM17: Eli Lilly (LLY) Not Looking for a Mega-Merger But Stays Open to Other M&A Deals 1/11/2017
Debt-Ridden Valeant (VRX) Offloads Dendreon (DNDN) for $819.9 Million Cash 1/11/2017
Pharma Bro Martin Shkreli's Twitter Account Suspended After Harassing Journalist 1/10/2017
Trump's Defense Pick Officially Cuts Ties With Theranos 1/10/2017
Troubled Theranos Pink Slips Another 41% of Workforce 1/10/2017
Bay Area Genetic Testing Firm Counsyl Lays Off Oncology Sales Team 1/9/2017
Here’s What You Need to Know About Biotech and Pharma to Land a Job in 2017 1/9/2017
Former Biogen (BIIB) CEO to Helm Newly Launched Bay Area Startup Vir Biotechnology 1/9/2017
JPM17: Boardroom Ready Program Prepares 20 Women for Spots on Biotech Corporate Boards 1/9/2017
JPM17: One Year after ‘The Party,’ Michael Rice, LifeSci Advisors Spearhead Gender Diversity in Life Sciences 1/9/2017
JPM17: Prophase CEO Joins Boardroom Ready Program to Take Next Career Step 1/9/2017
JPM17: OncoGenex (OGXI) CMO Cindy Jacobs Looks to WIB Boardroom Ready Program to Reach Goal 1/9/2017
JPM17: A First: Women in Bio’s Cynthia Smith Tapped for Nivalis (NVLS) Board 1/9/2017
JPM17: A Year Later, Alison Arter Sees Progress with Women in Bio Boardroom Ready Program 1/9/2017
Amgen (AMGN) Shares Soar After Blocking Rivals From Selling Competing Cholesterol-Lowering Drug 1/6/2017
Bay Area's Dynavax (DVAX) Slashes Global Workforce by 38% in Restructuring 1/6/2017
Embattled Theranos Gets a New Landlord 1/6/2017
New Eli Lilly (LLY) CEO's First Move: Shakes Up Leadership Structure in Effort to Recover From Alzheimer's Drug Flop 1/6/2017
Novartis AG (NVS) Athens Offices Raided in Bribery Probe, Exec Threatens With Suicide at Nearby Hotel 1/6/2017
SoCal's Ionis Pharma (IONS) Stock Jolted by $1.6 Billion Cardio Drug Deal With This Big Pharma 1/6/2017
SoCal Biotech Arena (ARNA) Officially Bails on Weight Loss Drug to Focus on New Products 1/5/2017
Alexion (ALXN) Admits Senior Management Pressured Staff to Boost Soliris Sales 1/5/2017
Gilead (GILD) Poaches Cancer R&D Superstar From Novartis AG (NVS) 1/5/2017
How Boston’s Paratek Pharma (PRTK) is Taking Aim at Antibiotic Market and Could Add 85 Jobs 1/5/2017
Infinity Pharma (INFI) Promotes a Handful of Execs, Announces Retirement of R&D Head Effective Jan. 6 1/4/2017
Shire (SHPG) Sells RNA Therapy Program to RaNA Therapeutics for Stake in Company 1/4/2017
As Promised, Allergan (AGN) Unveils Single-Digit Price Hikes for 9 Brand Name Drugs 1/4/2017
New Jersey's Braeburn Pharma Files Paperwork for $150 Million IPO 1/4/2017
1 Bay Area and 1 Massachusetts Biotech That Made Investors Squeal With Glee Last Year 1/4/2017
Top Harvard Scientist Retracts Diabetes Breakthrough Paper 1/4/2017
Chinese Upstart Ascletis Bags $100 Million in Series B Financing 1/4/2017
Stem Cell Company Cellular Dynamics Expands and Relocates New Headquarters 1/3/2017
7 Biotech Stocks to Watch in 2017 1/3/2017
Fortress Biotech (FBIO) Surged After Reporting Big Success With CAR-T Cancer Approach 12/30/2016
Solid as a Rock, RAUMEDIC Continues U.S. Hiring Spree in 2017 12/30/2016
Innocoll (INNL) Shares Tumble After FDA's Refusal to File Xaracoll NDA 12/30/2016
Like It or Not: Here's How Much Biogen (BIIB)’s Spinraza Will Cost 12/30/2016
Provectus Fires Peter Culpepper as Interim CEO and COO 12/30/2016
Investors, Put Your Emotions Aside: There is Hope for Valeant (VRX) in 2017 12/29/2016
Up-and-Coming Tedor Pharma Expands and Adds New Jobs 12/29/2016
FDA Approves First-Ever Treatment for Spinal Muscular Atrophy; Ionis Pharma (IONS), Biogen (BIIB) Seal Victory 12/29/2016
3 Worst Performing Pharma Stocks for 2016 12/29/2016
A Turnaround: Regeneron (REGN) Eyes a Comeback in 2017 12/28/2016
The 7 Worst Clinical Disasters of 2016 12/27/2016
California Biotech ChromaDex, Inc. to Set Up New R&D Plant in Longmont 12/27/2016
Hemostemix to Reorganize; Appoints New Board and Executive Team 12/27/2016
After Fraud Probe, Alexion (ALXN) Reports Failed Soliris Trial 12/27/2016
Tolero Pharmaceuticals to Be Acquired for Up to $780 Million 12/27/2016
Massachusetts Biotech OvaScience (OVAS) Slashes 30% of Workforce; CEO and COO Resign 12/27/2016
Ophthotech (OPHT) Clinical Disaster Spurs Massive Layoffs 12/27/2016
Sinovac Biotech Ltd. (SVA) CEO Reportedly Bribed Chinese FDA, Buyout Offers Could Be in Jeopardy 12/22/2016
This is Why Biogen (BIIB)’s Stock is Set to Soar in 2017 12/22/2016
Roche (RHHBY) Takes a Win as Emicizumab Hemophilia Drug Succeeds in Phase III 12/22/2016
Bay Area’s CBT Pharma Plans to Launch 2 Phase I Trials in 2017 12/22/2016
Meet Biogen (BIIB)'s New CEO 12/21/2016
Acadia (ACAD) Stock Screams Upward; Primary Endpoint Met in Phase II Study of Pimavanserin for Alzheimer’s 12/21/2016
Effective Immediately: Bay Area IMPAX Labs (IPXL) Seeks New CEO 12/21/2016
Why This Biotech Stock Should Be on Everyone's Christmas List 12/21/2016
5 Life Science Stocks Are Breaking Out This Christmas 12/20/2016
An Abandoned Pfizer (PFE) Drug Turns People Into 'Zombies' 12/20/2016
AstraZeneca PLC (AZN) Exec Jumps Ship to Become Innate Pharma (IPH.PA ) CEO 12/20/2016
White House Kills Plan for Drug Price Cap 12/19/2016
FDA Drops Black Box Warning on Pfizer (PFE)'s Anti-Smoking Drug Chantix 12/19/2016
Wanted: Recipharm AB Seeks New CFO Immediately 12/19/2016
The 5 Best Biopharma CEOs of 2016 Are... 12/19/2016
Gilead (GILD) Sinks, Will Pay Rival $2.54 Billion for a Patent Dispute 12/19/2016
GlaxoSmithKline (GSK)'s New R&D Center to House 450 Scientists and Support Staff, Will Create Up to 200 New Jobs 12/16/2016
And the Trophy for the Worst Biopharma CEO Of 2016 Goes to... 12/16/2016
New York’s Cellectis (ALCLS) Looks to 2017 for Clinical Trials of AML Treatment 12/16/2016
Booming Regeneron (REGN) Buys Another Building in New York 12/16/2016
Celgene (CELG), Evotec AG (EVTG.F) Ink $295 Million Drug Discovery Pact 12/16/2016
Flagship Wants a Startup Feel, Changes Name and Creates $285 Million 'Special Opportunities' Fund 12/15/2016
Ackman Drops Some Valeant (VRX) Shares, Papa Blames Media for Plummeting Share Prices 12/15/2016
INC Research (INCR) Creating 550 New Jobs in HQ Move 12/14/2016
Siemens Healthineers (SI)' $300 Million Expansion to Create Up to 700 New Jobs in Massachusetts 12/14/2016
Bay Area's Harpoon Therapeutics Taps Former Kolltan Pharma Exec as New CEO 12/14/2016
This Man Could be Trump's Frontrunner for Top FDA Job 12/14/2016
Look Who Just Joined Embattled Theranos' Roster 12/14/2016
Top 3 Most Profitable Companies in Biotech 12/14/2016
New York Bets $650 Million to Spark a Biotech Boom 12/13/2016
Alexion (ALXN) CEO and CFO Abruptly Step Down, Former AstraZeneca PLC (AZN) CEO Named New Leader 12/13/2016
A Look Into BioMarin (BMRN)'s Spanking New R&D Center 12/13/2016
How You Could Get Gilead (GILD) to Help You Make $30,000 a Year in Retirement 12/13/2016
Ophthotech (OPHT) Plunges as Wet AMD Drug Combo Trials With Novartis AG (NVS) Flops in Phase III Studies 12/13/2016
How This Former Biotech Darling Could be the New Theranos 12/13/2016
AstraZeneca PLC (AZN) to Eliminate 700 U.S. Jobs 12/12/2016
Top INSYS Sales Execs Allegedly Took Doctor Out for "One of the Best Nights of His Life” to Boost Drug Sales 12/9/2016
Gilead (GILD) CEO Remorseful Over Sovaldi's $1,000 Per Pill Price Tag 12/9/2016
3 Biotechs That Could Peak in 2017 12/9/2016
Read Trump's Lips: These Words Sent Biotech Stocks Reeling 12/9/2016
Peter Thiel Touts Ally for Top Job at the FDA or a Role at HHS 12/9/2016
So Long, Farewell: Head of Novartis AG (NVS)'s Shuttered CAR-T Unit to Helm Biotech Upstart Tmunity 12/8/2016
Horizon Pharma (HZNP) Craters as Rare Neuromuscular Drug Flunks Late-Stage Study 12/8/2016
Endo International (ENDP) Cuts 375-Member U.S. Branded Pain Sales Field Force 12/8/2016
Gladstone Institute Spinout Tenaya Therapeutics Launches With $50 Million 12/8/2016
Bay Area's Anthera Names a New CEO in Shakeup 12/7/2016
4 Massachusetts Biotechs Making Waves at American Society of Hematology 12/7/2016
Mylan (MYL) to Pink Slip Less Than 10% of Its Global Workforce, Actual Number Unknown 12/7/2016
Celgene (CELG) Decides to Not Move Forward With Phase III Portion of tnAcity 12/7/2016
Emails Reveal Theranos Never Saw it Coming, Predicted Revenue of Nearly $2 Billion for 2016 12/7/2016
Pfizer (PFE) Fined a Record $107 Million for Ramping Up Epilepsy Drug Price by as Much as 2,600% 12/7/2016
10 Major Pharma and FDA Catalysts Coming in December 12/6/2016
Eli Lilly (LLY) to Begin Axing Hundreds of Sales Jobs Early 2017 12/6/2016
Novartis AG (NVS)’ CAR-T Drug Sends 82% of Patients’ Blood Cancer into Remission, Eyes 2017 for Marketing 12/6/2016
Theranos Cleans House, Gets Rid of Some High-Profile Board Members 12/5/2016
Massachusetts' Selecta (SELB) Wrangles $890 Million+ R&D Deal Out of Spark Therapeutics (ONCE) 12/5/2016
Top 7 Jaw-Dropping Pipeline Blowups This Year 12/5/2016
2 Bay Area and 1 Massachusetts Biotech Stocks That Could Double in 2017 12/5/2016
Top 10 Nonscientific Skills Scientists Often Lack That Can Derail Their Careers 12/5/2016
High School Students "Punched" Martin Shkreli in the Face by Recreating $750 HIV Pill for a Mere $2 12/2/2016
Floundering SoCal Biotech Arrowhead Pharma (ARWR) Fires CSO, Effective Later This Month 12/2/2016
It's Confirmed! Merck & Co. (MRK) Inks Huge Space in the Bay Area 12/2/2016
Another Reason Biotech's Trump-Bump Won't Last 12/2/2016
bluebird bio (BLUE), Celgene (CELG)'s Multiple Myeloma CAR-T Drug Shines in Tiny Study 12/2/2016
New Boston Biotech Axial Biotech Launches With $19.15 Million and Will be Helmed by AbbVie (ABBV)-GlaxoSmithKline (GSK) Vet 12/1/2016
This One Biopharma Made the 10 Richest Companies in the U.S. List 12/1/2016
Attention, Please: Here Are 7 Career Tips From Fresh New Science Grads 12/1/2016
10 Biotechs That Could be Bought Out Thanks to the Trump Bump 11/30/2016
CytRx (CYTR) Plans to File NDA for Once-Failed Sarcoma Drug While Columnist Raises Questions Over Efficacy and CEO Salary Amid Struggle 11/30/2016
Novo Nordisk A/S (NVO) Yanks Ads Off of Conservative Site Founded by Trump's New Chief Strategist Stephen Bannon 11/29/2016
President-Elect Trump Set to Debut Dream Team for Healthcare Reform 11/29/2016
How Rupert Murdoch and Other Big Names are Tied to the Theranos Saga 11/29/2016
Amicus (FOLD) Plummets on 3-Year Delay to U.S. Fabry Drug FDA Filing Plan 11/29/2016
Patheon (PTHN) Takes Over Roche (RHHBY)'s North Carolina Facility, Saving 200 Jobs 11/29/2016
Latest Deaths in Juno (JUNO) Trial Puts Unwanted Limelight on the FDA 11/29/2016
Juno (JUNO) Halts CAR-T Trial for Second Time Following Additional Patient Deaths 11/28/2016
How Donald Trump Could Disrupt the FDA 11/28/2016
Pfizer (PFE) Nixes €400 Million Ireland Expansion and the Promise of 350 Jobs After Drug Setback 11/28/2016
'Retired' Former Novartis AG (NVS) R&D Cancer Head Returns for a New Gig at the Dana-Farber Cancer Institute 11/28/2016
Former Allergan (AGN) Exec Who Now Helms Chase Pharma Inks $1 Billion Pact With Brent Saunders and His New Gang 11/28/2016
Famed Attorney Officially Cuts Ties With Theranos 11/28/2016
World's Richest Doctor Patrick Soon-Shiong Meets With President-Elect Donald Trump 11/23/2016
This Could be The Reason Elizabeth Holmes is Still Leading Theranos 11/23/2016
Booming Shire (SHPG) to Take Over Sanofi Genzyme (SNY)'s HQ in Kendall Square, Eyes Hiring Another 400 Employees 11/23/2016
Investors Upset as Acorda (ACOR) Abandons Development of Another Drug After Phase II Flop 11/22/2016
The 27-Year Old Who Blew Up Theranos is the Grandson of a Company Director 11/21/2016
Struggling OncoGenex (OGXI) Axes More Jobs to Conserve Cash 11/18/2016
As Eli Lilly (LLY)'s ALZ Data Looms, Here Are Some Things Investors Need to Know 11/18/2016
Famed Short-Seller Says This Drug Stock is One You Need to Drop ASAP 11/18/2016
The Murder of a Thermo Fisher Scientific (TMO) Employee and the Missing Thumb Drive 11/17/2016
Two Private Investigators Accuse GlaxoSmithKline (GSK) of Hiring Them Under False Pretenses 11/17/2016
Cambridge Upstart Magenta Therapeutics Bags $48.5 Million and Will be Helmed by Former GlaxoSmithKline (GSK) R&D Head 11/17/2016
Celgene (CELG) Exec Out as Trump Puts Vice President Elect Leader of Transition Effort 11/16/2016
Theranos Allegedly Voided 31,000 Test Reports Provided to Walgreens Customers 11/16/2016
China Takes Lead in CRISPR Race, Will Test on a Human for the First Time 11/16/2016
GlaxoSmithKline (GSK) Dumps $250 Million Into 'Smart Labs' That Will House 3,200 R&D Staffers 11/16/2016
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract 11/16/2016
Top 10 Amgen (AMGN) Scholars to Watch Set to Impact the Future of Science and Medicine 11/16/2016
Biogen (BIIB) Taps Former Spark Therapeutics (ONCE) Exec and a Finance Vet for Hemophilia Spin-off Company Bioverativ 11/15/2016
Bristol-Myers Squibb (BMY) Slams Down $100 Million to Make a Play Into NASH 11/14/2016
Bay Area's Dynavax (DVAX) Plunges After the FDA Spurns HEPLISAV-B Again 11/14/2016
Going Up Against AbbVie (ABBV)'s Humira, Johnson & Johnson (JNJ) Presents Less-Than-Stellar Phase III Data 11/14/2016
Almac Group to Expand and Create 312 New Jobs at U.S. Headquarters 11/14/2016
3 Reasons That Make Biogen (BIIB) the King of a Crumbling Empire 11/14/2016
Celgene (CELG) Exec May be a Dark Horse Candidate for Donald Trump's Secretary of Health and Human Services 11/11/2016
Why Investors Should Buy (and Avoid) Merck & Co. (MRK) 11/11/2016
AstraZeneca PLC (AZN) Faces Another R&D Setback as Plans to File for Early Approval for Cancer Med are Scrapped 11/10/2016
Biotech Stocks Jump as Donald Trump Clinches Presidency in Major Upset 11/9/2016
3 Pharmas Relying on Innovation, Not Drug Price Increases for Growth 11/9/2016
FDA Slaps Clinical Hold on Arrowhead Pharma (ARWR)'s Hep B Study 11/9/2016
Q3 Report Reveals Kadmon Has Quietly Reduced 15% of Workforce Since July 11/9/2016
CEO Christopher Weber Trims Takeda (TKPYY)'s Fat and Builds Muscle in Much-Needed Areas 11/8/2016
With No Products and a Very Weak Revenue, Here's What Makes Kite Pharma (KITE) So Mighty 11/8/2016
2 Biotech Stocks to Have in Your Portfolio if Donald Trump Wins the Election 11/8/2016
Bone Therapeutics Taps a New CEO, Drops Plan to Initiate Cell Therapy Trial in the U.S. 11/8/2016
Merck KGaA (MKGAF.PK) Staffers Demand Severance Payments 11/7/2016
Bernie Sanders Asks the DOJ to Investigate Eli Lilly (LLY), Novo Nordisk A/S (NVO) and Sanofi (SNY) 11/7/2016
Fortress Biotech (CNDO) Forms Cellvation, Taps Forest (FRX), Life Technologies (LIFE) Alum as Interim CEO 11/7/2016
Alere (ALR) Plunges After Its Diabetes Unit Was Removed From Medicare for Allegedly Billing 211 Dead People 11/4/2016